Low-Protein Diet Induces IRE1α-Dependent Anticancer Immunosurveillance

Archive ouverte

Rubio-Patiño, Camila | Bossowski, Jozef P | de Donatis, Gian Marco | Mondragón, Laura | Villa, Elodie | Aira, Lazaro E | Chiche, Johanna | Mhaidly, Rana | Lebeaupin, Cynthia | Marchetti, Sandrine | Voutetakis, Konstantinos | Chatziioannou, Aristotelis | Castelli, Florence | Lamourette, Patricia | Chu-Van, Emeline | Fenaille, François | Avril, Tony | Passeron, Thierry | Patterson, John B | Verhoeyen, Els | Bailly-Maitre, Beatrice | Chevet, Eric | Ricci, Jean-Ehrland

Edité par CCSD ; Elsevier -

International audience. Dietary restriction (DR) was shown to impact on tumor growth with very variable effects depending on the cancer type. However, how DR limits cancer progression remains largely unknown. Here, we demonstrate that feeding mice a low-protein (Low PROT) isocaloric diet but not a low-carbohydrate (Low CHO) diet reduced tumor growth in three independent mouse cancer models. Surprisingly, this effect relies on anticancer immunosurveillance, as depleting CD8 T cells, antigen-presenting cells (APCs), or using immunodeficient mice prevented the beneficial effect of the diet. Mechanistically, we established that a Low PROT diet induces the unfolded protein response (UPR) in tumor cells through the activation of IRE1α and RIG1 signaling, thereby resulting in cytokine production and mounting an efficient anticancer immune response. Collectively, our data suggest that a Low PROT diet induces an IRE1α-dependent UPR in cancer cells, enhancing a CD8-mediated T cell response against tumors.

Consulter en ligne

Suggestions

Du même auteur

GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism

Archive ouverte | Mondragón, Laura | CCSD

International audience

GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors

Archive ouverte | Chiche, Johanna | CCSD

International audience. Diffuse large B cell lymphoma (DLBCL) is a heterogeneous disease treated with anti-CD20-based immuno-chemotherapy (R-CHOP). We identified that low levels of GAPDH predict a poor response to R...

IRE1α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune response

Archive ouverte | Martinez-Turtos, Adriana | CCSD

International audience. IRE1α is one of the three ER transmembrane transducers of the Unfolded Protein Response (UPR) activated under endoplasmic reticulum (ER) stress. IRE1α activation has a dual role in cancer as ...

Chargement des enrichissements...